Western blot analysis revealed that MDA-MB-231 breast cancer cells treated with Tacotanina, decreased the levels of XIAP at 24 h while the levels of cleaved-casp-3 were enhanced, such as occurred in cells treated with PTX (Figure 5A). The gene discussed is CASP3; the disease is breast carcinoma.